Cargando…

Angiogenesis in pre-malignant conditions

Evidence from human studies suggests that angiogenesis commences during the pre-malignant stages of cancer. Inhibiting angiogenesis may, therefore, be of potential value in preventing progression to invasive cancer. Understanding the mechanisms inducing angiogenesis in these lesions and identificati...

Descripción completa

Detalles Bibliográficos
Autores principales: Menakuru, S R, Brown, N J, Staton, C A, Reed, M W R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607228/
https://www.ncbi.nlm.nih.gov/pubmed/18941463
http://dx.doi.org/10.1038/sj.bjc.6604733
_version_ 1782163033523486720
author Menakuru, S R
Brown, N J
Staton, C A
Reed, M W R
author_facet Menakuru, S R
Brown, N J
Staton, C A
Reed, M W R
author_sort Menakuru, S R
collection PubMed
description Evidence from human studies suggests that angiogenesis commences during the pre-malignant stages of cancer. Inhibiting angiogenesis may, therefore, be of potential value in preventing progression to invasive cancer. Understanding the mechanisms inducing angiogenesis in these lesions and identification of those important in human tumourigenesis are necessary to develop translational strategies that will help realise the goal of angioprevention.
format Text
id pubmed-2607228
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-26072282009-12-09 Angiogenesis in pre-malignant conditions Menakuru, S R Brown, N J Staton, C A Reed, M W R Br J Cancer Minireview Evidence from human studies suggests that angiogenesis commences during the pre-malignant stages of cancer. Inhibiting angiogenesis may, therefore, be of potential value in preventing progression to invasive cancer. Understanding the mechanisms inducing angiogenesis in these lesions and identification of those important in human tumourigenesis are necessary to develop translational strategies that will help realise the goal of angioprevention. Nature Publishing Group 2008-12-09 2008-10-21 /pmc/articles/PMC2607228/ /pubmed/18941463 http://dx.doi.org/10.1038/sj.bjc.6604733 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Minireview
Menakuru, S R
Brown, N J
Staton, C A
Reed, M W R
Angiogenesis in pre-malignant conditions
title Angiogenesis in pre-malignant conditions
title_full Angiogenesis in pre-malignant conditions
title_fullStr Angiogenesis in pre-malignant conditions
title_full_unstemmed Angiogenesis in pre-malignant conditions
title_short Angiogenesis in pre-malignant conditions
title_sort angiogenesis in pre-malignant conditions
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607228/
https://www.ncbi.nlm.nih.gov/pubmed/18941463
http://dx.doi.org/10.1038/sj.bjc.6604733
work_keys_str_mv AT menakurusr angiogenesisinpremalignantconditions
AT brownnj angiogenesisinpremalignantconditions
AT statonca angiogenesisinpremalignantconditions
AT reedmwr angiogenesisinpremalignantconditions